These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 1351927)
1. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors. Trovero F; Hervé D; Blanc G; Glowinski J; Tassin JP J Neurochem; 1992 Jul; 59(1):331-7. PubMed ID: 1351927 [TBL] [Abstract][Full Text] [Related]
2. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro. Hess EJ; Battaglia G; Norman AB; Creese I Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940 [TBL] [Abstract][Full Text] [Related]
3. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists. Giorgi O; Biggio G Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234 [TBL] [Abstract][Full Text] [Related]
4. Functional recovery of D1 dopamine receptor-mediated stimulation of rat striatal adenylate cyclase activity following irreversible receptor modification by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): evidence for spare receptors. Battaglia G; Norman AB; Hess EJ; Creese I Neurosci Lett; 1986 Sep; 69(3):290-5. PubMed ID: 2945128 [TBL] [Abstract][Full Text] [Related]
5. Differential effect of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on [3H]SCH23390 and [3H]forskolin binding in rat striatum. Norman AB; Wachendorf TJ; Sanberg PR Life Sci; 1989; 44(13):831-6. PubMed ID: 2648096 [TBL] [Abstract][Full Text] [Related]
6. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase. Makman MH; Dvorkin B Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967 [TBL] [Abstract][Full Text] [Related]
7. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo. Riddall DR Eur J Pharmacol; 1992 Jan; 210(3):279-84. PubMed ID: 1351844 [TBL] [Abstract][Full Text] [Related]
8. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics. Meller E; Bohmaker K; Goldstein M; Friedhoff AJ J Pharmacol Exp Ther; 1985 Jun; 233(3):656-62. PubMed ID: 2861276 [TBL] [Abstract][Full Text] [Related]
9. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat. Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD Neuropharmacology; 1994 May; 33(5):647-55. PubMed ID: 7936100 [TBL] [Abstract][Full Text] [Related]
10. D1 dopamine receptors in the rat retina: effect of dark adaptation and chronic blockade by SCH 23390. Porceddu ML; De Montis G; Mele S; Ongini E; Biggio G Brain Res; 1987 Oct; 424(2):264-71. PubMed ID: 2960425 [TBL] [Abstract][Full Text] [Related]
11. Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum. Giorgi O; De Montis G; Porceddu ML; Mele S; Calderini G; Toffano G; Biggio G Brain Res; 1987 Oct; 432(2):283-90. PubMed ID: 2960426 [TBL] [Abstract][Full Text] [Related]
12. Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor. Andersen PH; Braestrup C J Neurochem; 1986 Dec; 47(6):1822-31. PubMed ID: 2945903 [TBL] [Abstract][Full Text] [Related]
13. Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a novel rotational model to investigate dopamine receptor interactions. Giorgi O; Biggio G Pharmacol Biochem Behav; 1990 Apr; 35(4):877-84. PubMed ID: 1971721 [TBL] [Abstract][Full Text] [Related]
14. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine. Burger LY; Martin-Iverson MT Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985 [TBL] [Abstract][Full Text] [Related]
15. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling. Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052 [TBL] [Abstract][Full Text] [Related]
16. Dopaminergic behaviors and signal transduction mediated through adenylate cyclase and phospholipase C pathways. Undie AS; Berki AC; Beardsley K Neuropharmacology; 2000; 39(1):75-87. PubMed ID: 10665821 [TBL] [Abstract][Full Text] [Related]
17. A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum. Andersen PH; Grønvald FC; Jansen JA Life Sci; 1985 Nov; 37(21):1971-83. PubMed ID: 2415793 [TBL] [Abstract][Full Text] [Related]
18. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats. Lévesque D; Di Paolo T Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586 [TBL] [Abstract][Full Text] [Related]
19. Irradiation inactivation studies of the dopamine D1 receptor and dopamine-stimulated adenylate cyclase in rat striatum. Andersen PH; Nielsen M Neurosci Lett; 1987 Dec; 83(1-2):167-72. PubMed ID: 2964568 [TBL] [Abstract][Full Text] [Related]
20. Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine stimulated adenylate cyclase activity. Cameron DL; Crocker AD Neurosci Lett; 1988 Jul; 90(1-2):165-71. PubMed ID: 3045699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]